ID   ESIBIe003-A-7
AC   CVCL_C3LB
SY   HES-3_44; IRF8-/- ES cell; UKAe004-A-7
DR   BioSamples; SAMEA8325230
DR   hPSCreg; ESIBIe003-A-7
DR   Wikidata; Q114311383
RX   PubMed=28090699;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 5358; IRF8.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7158 ! HES-3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
RX   PubMed=28090699; DOI=10.1002/stem.2565;
RA   Sontag S., Forster M., Qin J., Wanek P., Mitzka S., Schuler H.M.,
RA   Koschmieder S., Rose-John S., Sere K., Zenke M.;
RT   "Modelling IRF8 deficient human hematopoiesis and dendritic cell
RT   development with engineered iPS cells.";
RL   Stem Cells 35:898-908(2017).
//